Login to Your Account



Avigen Dropping AAV Gene Therapy, Favoring Tradition

By Karen Pihl-Carey


Wednesday, April 6, 2005
In what has proved to be a slow and somewhat bumpy road for gene therapy research, one company - Avigen Inc. - is gracefully bowing out in order to focus on more traditional drug development. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription